非输血依赖型地中海贫血患者的器官特异性铁过载:定量MRI评估的启示
研究纳入34例非输血依赖型地中海贫血(NTDT)患者(28例未行铁螯合治疗、6例行铁螯合治疗)和15名正常对照,于2022年12月至2024年7月行MRI T2*扫描测量垂体、肾皮质、心脏、肝脏、胰腺、脾脏T2*并评估肝脾体积。未行铁螯合治疗的NTDT患者中,肝脏铁过载19例、肾脏铁过载9例、脾脏铁过载4例;与对照组相比,未行铁螯合治疗的NTDT患者肝脏、肾脏、脾脏T2*更低(p<0.05)。结论认为NTDT患者存在显著的器官特异性铁过载,尤其以肝脏、肾脏和脾脏为著,不同器官铁水平间的相关性提示铁蓄积机制相互关联,这些发现强调定期MRI筛查对监测和管理NTDT患者铁过载的重要性。
要点
- 未行铁螯合治疗的NTDT患者中,肝脏铁过载19例、肾脏9例、脾脏4例。
- 肾脏或脾脏铁异常的NTDT患者中,76.9%合并肝脏铁过载。
- 未行铁螯合治疗的NTDT患者肝脏、肾脏、脾脏T2*低于对照组(p<0.05)。
核心结论
- NTDT患者存在显著的器官特异性铁过载,尤其以肝脏、肾脏和脾脏为著,不同器官铁水平间的相关性提示铁蓄积机制相互关联,这些发现强调定期MRI筛查对监测和管理NTDT患者铁过载的重要性。
研究设计与样本
- 研究纳入34例NTDT患者(28例未行铁螯合治疗、6例行铁螯合治疗)和15名正常对照,于2022年12月至2024年7月行MRI T2*扫描,测量垂体、肾皮质、心脏、肝脏、胰腺、脾脏T2*并评估肝脾体积。
关键影像表现/征象
- 未行铁螯合治疗的28例NTDT患者中,肝脏铁过载19例、肾脏铁过载9例、脾脏铁过载4例。
- 肾脏和脾脏铁异常的NTDT患者中,76.9%存在肝脏铁过载。
- 与对照组相比,未行铁螯合治疗的NTDT患者肝脏、肾脏、脾脏T2*更低(p<0.05)。
- 心脏T2*与肾脏T2*相关(r=0.480,p=0.010),心脏T2*与胰腺T2*相关(r=0.411,p=0.037)。
- 肝脏T2*与脾脏T2*相关(r=0.479,p=0.011),胰腺T2*与垂体T2*相关(r=-0.433,p=0.031)。
临床应用与阅片要点
- 对NTDT患者应定期行MRI T2*筛查以监测和管理铁过载(原文结论强调定期MRI筛查的重要性)。
- 阅片时应关注肝脏、肾脏、脾脏的T2*降低,并注意肾脏或脾脏铁异常者多合并肝脏铁过载(76.9%)。
- 心脏T2*与肾脏T2*、胰腺T2*相关,肝脏T2*与脾脏T2*相关,胰腺T2*与垂体T2*相关,提示评估多器官铁沉积的相互关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To elucidate the iron load in different organs of non-transfusion-dependent thalassemia (NTDT) patients using magnetic resonance imaging (MRI) T2* scan.
METHODS: Thirty-four NTDT patients, including 28 NTDT iron chelation without and 6 NTDT with iron chelation, together with 15 normal controls, underwent MRI examination between December 2022 and July 2024 were enrolled in the study. Measured T2* of the pituitary gland, kidney cortex, heart, liver, pancreas, spleen. Liver and spleen volumes were evaluated.
RESULTS: Of the 28 patients in NTDT without iron chelation group, 19 patients with iron overload in the liver, 9 patients with iron overload in the kidneys, and 4 patients with iron overload in the spleen. Most patients with abnormal kidney and spleen iron (76.9 %) had liver iron overload. Compared with the control group, NTDT without iron chelation patients had lower T2* in the liver, kidney, and spleen (p < 0.05). And heart T2* was correlated with kidney T2* (r = 0.480, p = 0.010) and pancreas (r = 0.411, p = 0.037). Liver T2* was correlated with spleen T2* (r = 0.479, p = 0.011). Pancreas T2* was correlated with pituitary T2* (r = -0.433, p = 0.031).
CONCLUSIONS: NTDT patients exhibit significant organ-specific iron overload, particularly in the liver, kidneys, and spleen. The correlations between iron levels in different organs suggest interconnected mechanisms of iron accumulation. These findings highlight the importance of regular MRI screening to monitor and manage iron overload in NTDT patients.
引用
- Ning X, Tan S, Peng F, et al. Organ-Specific Iron Overload in Non-Transfusion-Dependent Thalassemia Patients: Insights from Quantitative MRI Evaluation. Eur J Radiol. 2024. PMID: 39447423. doi:10.1016/j.ejrad.2024.111750
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。